Effects of a fucoidan on the activation of plasminogen by u-PA and t-PA

Thrombosis Research

Volumn 99, Issue 6, 2000, Pages 623-634

  Nishino, Takashi ^a   Yamauchi, Tomoko ^b   Horie, Mariko ^b   Nagumo, Terukazu ^b   Suzuki, Haruo ^a  

^a Department of Biosciences   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Fibrinolysis; Fucoidan; Plasminogen; Tissue type plasminogen activator; Urokinase type plasminogen activator

Indexed keywords

FUCOIDIN; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR;

ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FIBRINOLYSIS; KINETICS; NONHUMAN; PRIORITY JOURNAL; SEAWEED;

ANTICOAGULANTS; CHROMOGENIC COMPOUNDS; HEPARIN; HUMANS; KINETICS; MODELS, THEORETICAL; MOLECULAR WEIGHT; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATORS; POLYSACCHARIDES; SEAWEED; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 0034666707     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00289-9     Document Type: Article

References (36)

1. Rijken D.C., Wijngaards G., Welbergen J. Immunological characterization of plasminogen activator activities in human tissue and body fluids. J Lab Clin Med. 97:1981;477-486.
2. Wallen P., Wiman B. Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen. Biochim Biophys Acta. 257:1972;122-134.
3. Violand B.N., Castellino F.J. Mechanism of the urokinase-catalyzed activation of human plasminogen. J Biol Chem. 251:1976;3906-3912.
4. 2-terminal sequences of mammalian plasminogens and plasmin S-carboxymethyl heavy (A) and light (B) chain derivatives. A re- evaluation of the mechanism of activation of plasminogen. J Biol Chem. 248:1973;7242-7246.
5. Thorsen S. The mechanism of plasminogen activation and the variability of the fibrin effector during tissue-type plasminogen activator-mediated fibrinolysis. Ann NY Acad Sci. 301:1992;52-63.
6. Camiolo S.M., Thorsen S., Astrup T. Fibrinogenolysis and fibrinolysis with tissue plasminogen activator, urokinase, streptokinase-activated human globulin and plasmin. Proc Soc Exp Biol Med. 138:1971;277-280.
7. Hoylaerts M., Rijken D.C., Lijnen H.R., Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem. 257:1982;2912-2919.
8. Markwardt F., Klöcking H.P. Heparin-induced release of plasminogen activator. Haemostasis. 6:1977;370-374.
9. Andrade-Gordon P., Strickland S. Interaction of heparin with plasminogen activators and plasminogen. effects on the activation of plasminogen Biochemistry. 25:1986;4033-4040.
10. Pâques E.-P., Stöhr H.-A., Heimburger N. Study on the mechanism of action of heparin and related substances on the fibrinolytic system. relationship between plasminogen activators and heparin Thromb Res. 42:1986;797-807.
11. Rosa A.T., Rotshild A.M., Rotshild Z. Fibrinolytic activity evoked in plasma of the normal and adrenalectomized rat by cellulose sulfate. Br J Pharmacol. 45:1972;470-475.
12. Kumada T., Abiko Y. Fibrinolytic action of a new semi-synthetic polysaccharide sulfate, galactan polysulfate (DH6322), in the rat. Thromb Res. 39:1985;9-19.
13. Nagumo T., Nishino T. Fucan sulfates and their anticoagulant activities. Dumitriu S. Polysaccharides in Medicinal Applications. 1996;545-574 Marcel Dekker, New York/Basel.
14. Baba M., Snoeck R., Pauwels R., De Clerg E. Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicrob Agents Chemother. 32:1988;1742-1745.
15. Kobayashi T., Honke K., Miyazaki T., Matumoto K., Nakamura T., Ishizuka I., Makita A. Hepatocyte growth factor specifically binds to sulfoglycolipids. J Biol Chem. 269:1994;9817-9821.
16. Nishino T., Aizu Y., Nagumo T. Antithrombin activity of a fucan sulfate from the brown seaweed Ecklonia kurome. Thromb Res. 62:1991;765-773.
17. Nishino T., Fukuda A., Nagumo T., Fujihara M., Kaji E. Inhibition of the generation of thrombin and factor Xa by a fucoidan from the brown seaweed Ecklonia kurome. Thromb Res. 96:1999;37-49.
18. Soeda S., Sakaguchi S., Shimeno H., Nagamatsu A. Fibrinolytic and anticoagulant activities of high sulfated fucoidan. Biochem Pharmacol. 43:1992;1853-1858.
19. Doctor V.M., Hill C., Jackson G.J. Effect of fucoidan during activation of human plasminogen. Thromb Res. 79:1995;237-247.
20. Kawamura H., Watanabe I., Urano T., Takada Y., Takada A. The effects of polysaccharides on plasminogen activation by single chain- and two chain-tissue plasminogen activator. Thromb Res. 62:1991;481-490.
21. Takada Y., Urano T., Takada A. Effects of heparan sulfate analogue or other sulfated polysaccharides on the activation of plasminogen by t-PA or u-PA. Thromb Res. 73:1994;301-311.
22. Percival E., McDowell R.H. Chemistry and Enzymology of Marine Algal Polysaccharides. 1967;Academic Press, London. p. 157-64.
23. Patankar M.S., Oehninger S., Barnett T., Williams R.L., Clark G.F. A revised structure for fucoidan may explain some of its biological activities. J Biol Chem. 268:1993;21770-21776.
24. Nishino T., Kiyohara H., Yamada H., Nagumo T. An anticoagulant fucoidan from the brown seaweed Ecklonia kurome. Phytochemistry. 30:1991;535-539.
25. Nishino T., Nagumo T., Kiyohara H., Yamada H. Structural characterization of a new anticoagulant fucan sulfate from the brown seaweed Ecklonia kurome. Carbohydr Res. 211:1991;77-90.
26. Nishino T., Yokoyama G., Dobashi K., Fujihara M., Nagumo T. Isolation, purification, and characterization of fucose-containing sulfated polysaccharides from the brown seaweed Ecklonia kurome and their blood-anticoagulant activities. Carbohydr Res. 186:1989;119-129.
27. Wohl R.C., Summaria L., Robbins K.C. Kinetic of activation of human plasminogen by different activator species at pH 7.4 and 37°C. J Biol Chem. 255:1980;2005-2013.
28. Rydzewski A., Takada Y., Takada A. Stimulation of plasmin catalyzed conversion of single-chain to two-chain urokinase-type plasminogen activator by sulfated polysaccharides. Thromb Haemost. 62:1989;752-755.
29. Borza D.-B., Morgan W.T. Acceleration of plasminogen activation by tissue plasminogen activator on surface-bound histidine-prolin-rich glycoprotein. J Biol Chem. 272:1997;5718-5726.
30. Stein P.L., van Zonneveld A.J., Pannekoek H., Strickland S. Structural domains of human tissue-type plasminogen activator that confer stimulation by heparin. J Biol Chem. 264:1989;15441-15444.
31. Edelberg J.M., Pizzo S.V. Kinetic analysis of the effects of heparin and lipoproteins on tissue plasminogen activator mediated plasminogen activation. Biochemistry. 29:1990;5906-5911.
32. Stephens R.W., Bokman A.M., Myöhänen H.T., Reisberg T., Tapiovaara H., Pedersen N., Grøndahl-Hansen J., Llinas M., Vaheri A. Heparin binding to the urokinase kringle domain. Biochemistry. 31:1992;7572-7579.
33. Mangel W.F., Lin B.H., Ramakrishnan V. Characterization of an extremely large, ligand-induced conformational change in plasminogen. Science. 248:1990;69-73.
34. Violand B.N., Byrne R., Castellino F.J. The effect of alpha-, omega-amino acids on human plasminogen structure and activation. J Biol Chem. 253:1978;5395-5401.
35. Minix R., Doctor V.M. Interaction of fucoidan with proteases and inhibitors of coagulation and fibrinolysis. Thromb Res. 87:1997;419-429.
36. Soeda S., Ohmagari Y., Shimeno H., Nagamatsu A. Preparation of oversulfated fucoidan and evaluation of their antithrombotic activities. Thromb Res. 72:1993;247-256.